Utilization of narcotic drugs in outpatient and emergency pharmacy in a tertiary hospital
-
摘要: 目的 分析上海交通大学医学院附属第九人民医院门急诊麻醉药品的使用情况,为临床合理使用麻醉药品提供参考。 方法 收集本院2014年1-6月和2015年1-6月共2 940张麻醉药品处方,统计麻醉药品的用药品种,并对处方的使用科室、药品的用药频度(DDDs)和药物利用指数(DUI)进行数据统计分析。 结果 共涉及麻醉药品6种,其中针剂3种,片剂2种,外用贴剂1种。使用麻醉药品较多的科室分别是急诊科、放疗科、镇痛科。硫酸吗啡缓释片的DDDs最高,2015年1-6月盐酸哌替啶注射液的DDDs较2014年同期明显减少,硫酸吗啡缓释片和盐酸布桂嗪片的DUI有所升高。 结论 本院门急诊麻醉药品使用情况基本合理,但尚有个别医师在麻醉药品的用法、用量上存在不合理使用,应加强对其有针对性的培训。Abstract: Objective To review the usage of narcotic drugs at outpatient and emergency pharmacy in order to promote rational narcotic drug use. Methods A total of 2 940 narcotic prescriptions from outpatient and emergency pharmacy in our hospital during January to June, 2014 and 2015 were collected. Three parameters (the prescription department, DDDs and DUI) were analyzed statistically. Results Six narcotic drugs were involved, including three injections, two tablets and one external patch. Emergency Department, Radiotherapy Department and Analgesia Department are the top three high usage departments. Morphine sulfate sustained-release tablet had the highest DDDs. DDDs of pethidine hydrochloride injection during January to June, 2015 was significantly reduced compared to the same period in 2014. DUI of morphine sulfate sustained-release tablet and bucinnazine hydrochloride tablets increased to some extent. Conclusion The usage of narcotic drugs at outpatient and emergency pharmacy in our hospital was basically reasonable. A few physicians still had problems in proper indication and dosage with narcotic drug use. The specific training programs need to be in place for those physicians.
-
Key words:
- narcotic drug /
- prescription analysis /
- DDDs
-
[1] 陈新谦,金有豫,汤光.新编药物学[M].17版.北京:人民卫生出版社,2011:164-179. [2] 夏羽菡,周荣.2007-2010年我院门诊麻醉性镇痛药应用分析[J].中国医院用药评价与分析,2012,12(1):45-47. [3] 唐小婷,张鹏,陈艳梅,等. 2008-2012年遂宁市中心医院门诊麻醉药品应用分析[J].中国医院用药评价与分析,2014,14(1):16-18. [4] 周江聪.2006~2008年本院麻醉药品用药情况分析[J].中国现代药物应用,2009, 3(17):99-100. [5] 郝素芳.我院麻醉药品的使用及合理用药分析[J].当代医学,2012,18(10):133-134. [6] Laval G, Sang B, Mallaret M, et al. New Level Ⅲ opioids of the World Health Organization[J].Rev Med Interne,2002, 23(1):55-70. -
![WeChat](/fileYXSJZZ/journal/article/yxsjzz/2016/6/PIC/wechat_cn_20160621.jpg)
计量
- 文章访问数: 3279
- HTML全文浏览量: 366
- PDF下载量: 299
- 被引次数: 0